BR

Bharata Reddy Ganta

Active Director Designated Partner DIN 08586902
DIN 08586902 First appointment Oct 2019 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Bharata Reddy Ganta

Data last updated:

Bharata Reddy Ganta is a Designated Partner at Stenovel Biologics Llp (since 2019). The company operates in Healthcare.

DIN 08586902
Primary Designation Designated Partner
Industry Healthcare
First Appointment 15 Oct 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Oct 20192019Active

Board colleagues of Bharata Reddy Ganta

NameDINCompanyDesignation
Mohini Gunta09378719Stenovel Biologics LlpDesignated Partner
Venkateswarlu Elluru10603314Stenovel Biologics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Stenovel Biologics Llp
Premium access

Shareholding and investment profile for Bharata Reddy Ganta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharata Reddy Ganta

Bharata Reddy Ganta currently holds 1 directorship: Stenovel Biologics Llp (Designated Partner, since 15 Oct 2019).

Bharata Reddy Ganta was first appointed on 15 Oct 2019 as Designated Partner at Stenovel Biologics Llp.

The current boards of Bharata Reddy Ganta's companies include Mohini Gunta (Stenovel Biologics Llp), Venkateswarlu Elluru (Stenovel Biologics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available